Figure 2.

Improvement of at least 0.5 unit in health assessment questionnaire score at 2 years in patients who had early rheumatoid arthritis and were given etanercept or methotrexate (MTX). This was an open-label trial. Reproduced with permission from John Wiley & Sons, Inc. [24]. © 2002 American College of Rheumatology

Schwartzman et al. Arthritis Res Ther 2004 6(Suppl 2):S3-S11   doi:10.1186/ar1013